A randomized controlled trial of acetyl salicyclic acid in the secondary prevention of mortality from myocardial infarction

Elwood, Peter Creighton, Cochrane, A. L., Burr, Michael Leslie, Sweetnam, P. M., Williams, G., Welsby, E., Hughes, S. J. and Renton, R. 1974. A randomized controlled trial of acetyl salicyclic acid in the secondary prevention of mortality from myocardial infarction. BMJ 1 (5905) , pp. 436-440. 10.1136/bmj.1.5905.436

Full text not available from this repository.

Abstract

The results of a randomized controlled trial of a single daily dose of acetyl salicylic acid (aspirin) in the prevention of reinfarction in 1,239 men who had had a recent myocardial infarct were statistically inconclusive. Nevertheless, they showed a reduction in total mortality of 12% at six months and 25% at twelve months after admission to the trial. Further trials are urgently required to establish whether or not this effect is real.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	BMJ Publishing Group
ISSN:	0959-8138
Last Modified:	10 Jun 2023 01:15
URI:	https://orca.cardiff.ac.uk/id/eprint/59524

Citation Data

Cited 385 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item